These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25424217)

  • 21. Topical timolol treatment for periocular infantile haemangioma in the developing world.
    Jefferson RJ; Hildebrand GD
    Trop Doct; 2019 Jul; 49(3):246-248. PubMed ID: 31014195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical timolol for periocular hemangioma: report of further study.
    Ni N; Langer P; Wagner R; Guo S
    Arch Ophthalmol; 2011 Mar; 129(3):377-9. PubMed ID: 21403002
    [No Abstract]   [Full Text] [Related]  

  • 23. A controlled study of topical 0.25% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas.
    Chambers CB; Katowitz WR; Katowitz JA; Binenbaum G
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):103-6. PubMed ID: 22410658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
    Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
    Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
    Marey HM; Elmazar HF; Mandour SS; Khairy HA
    J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):37-42. PubMed ID: 28991344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical timolol for small infantile hemangioma: a new therapy option.
    Weissenstein A; Straeter A; Villalon G; Bittmann S
    Turk J Pediatr; 2012; 54(2):156-8. PubMed ID: 22734302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-pressure Glaucoma Treatment Study.
    Garudadri CS; Choudhari NS; Rao HL; Senthil S
    Am J Ophthalmol; 2011 Nov; 152(5):877; author reply 877-8. PubMed ID: 22017843
    [No Abstract]   [Full Text] [Related]  

  • 28. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
    Sorrell J; Chamlin SL
    Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic timolol exposure following topical application to infantile hemangiomas.
    Drolet BA; Boakye-Agyeman F; Harper B; Holland K; Lewandowski A; Stefanko N; Melloni C;
    J Am Acad Dermatol; 2020 Mar; 82(3):733-736. PubMed ID: 30790601
    [No Abstract]   [Full Text] [Related]  

  • 30. Beta blocker treatment for infantile hemangiomas.
    Rouhana HF; Fruge JH; Massengale WT
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical timolol gel for infantile hemangiomas: a pilot study.
    Pope E; Chakkittakandiyil A
    Arch Dermatol; 2010 May; 146(5):564-5. PubMed ID: 20479314
    [No Abstract]   [Full Text] [Related]  

  • 32. Spectral Doppler ultrasound for predicting long-term response to topical timolol in children with infantile hemangioma.
    He L; Huang G
    J Clin Ultrasound; 2017 Oct; 45(8):480-487. PubMed ID: 28369943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases.
    Chang TC; Estes R
    J AAPOS; 2014 Feb; 18(1):80-2. PubMed ID: 24568991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study.
    Tawfik AA; Alsharnoubi J
    Pediatr Dermatol; 2015; 32(3):369-76. PubMed ID: 25740672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First report of topical timolol treatment in primarily ulcerated perineal haemangioma.
    Cante V; Pham-Ledard A; Imbert E; Ezzedine K; Léauté-Labrèze C
    Arch Dis Child Fetal Neonatal Ed; 2012 Mar; 97(2):F155-6. PubMed ID: 22190187
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
    Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
    Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical Timolol for Infantile Hemangiomas: Evidence for Efficacy and Degree of Systemic Absorption.
    Weibel L; Barysch MJ; Scheer HS; Königs I; Neuhaus K; Schiestl C; Rentsch K; Müller DM; Theiler M
    Pediatr Dermatol; 2016; 33(2):184-90. PubMed ID: 26840644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.
    Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y
    Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Topical timolol in the treatment of periocular superficial infantile hemangiomas: a prospective study].
    Ye XX; Jin YB; Lin XX; Ma G; Chen XD; Qiu YJ; Chen H; Hu XJ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 May; 28(3):161-4. PubMed ID: 22870699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.